REVANCE THERAPEUTICS INC shareholders Q2 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ProShare Advisors LLC 16,288$412,2490.00%
Parallax Volatility Advisers, L.P. 25,000$632,7500.00%
Walleye Trading LLC 18,200$460,6420.00%
Rafferty Asset Management, LLC 9,013$228,1190.00%
Cubist Systematic Strategies, LLC 4,900$124,0190.00%
WASHINGTON TRUST Co 1,130$28,6000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 134,200$3,396,6020.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 139,738$3,536,7690.00%
VOYA INVESTMENT MANAGEMENT LLC 33,125$838,3940.00%
SIGNATUREFD, LLC 1,393$35,2570.00%
BELLEVUE ASSET MANAGEMENT, LLC 93$2,3530.00%
JANE STREET GROUP, LLC 111,987$2,834,3910.00%
AQR Capital Management 13,483$341,2550.00%
Parallax Volatility Advisers, L.P. 10,000$253,1000.00%
Washington Trust Advisors, Inc. 244$6,1760.00%
Walleye Capital LLC 7,900$199,9490.00%
BANK OF AMERICA CORP /DE/ 282,146$7,141,1160.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 80,700$2,042,5170.00%
PNC FINANCIAL SERVICES GROUP, INC. 429$10,8590.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.